An observational study in Acute ST-Elevation Myocardial Infarction, sponsored by Medical University Innsbruck. Recruiting at 2 sites in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-10.
Sponsored by Medical University Innsbruck · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in ST Elevation Myocardial Infarction with a site in Austria — 7 open to participants now, 9 under way, none of them phase 3. ST Elevation Myocardial Infarction · Austria.
Among the 23 studies in ST Elevation Myocardial Infarction with a site in Austria, this one is one of 4 that started in 2011, is one of 9 observational ones, and was the 14th registered.
855 studies on the registry are indexed under ST Elevation Myocardial Infarction; 201 are open to participants now.
Browse ST Elevation Myocardial Infarction studies →7 of the 23 studies in ST Elevation Myocardial Infarction with a site in Austria are open now. Recruiting first, the newest first:
Medical University Innsbruck · Sites in Austria
Ages 18–75 · Healthy volunteers
Medical University of Vienna · Sites in Austria
Ages 18+
Medical University Innsbruck · Sites in Austria, Germany
Ages 18+
RobotDreams GmbH · Sites in Austria
Ages 18+ · Healthy volunteers
Medical University Innsbruck · Sites in Austria, Germany
Ages 18–85
A study can be open while its sites in Austria have not opened yet or have stopped. Only those recruiting at a site in Austria →
Of the 124 ST Elevation Myocardial Infarction studies recruiting now, 78 (63%) set no upper age limit and 20 (16%) stop at 75 or younger; 10 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 4 · Phase 3 3 · Phase 4 1
First in 2007; this study’s year is marked. 4 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,500 is above the median of 340 across 298 observational studies indexed under ST Elevation Myocardial Infarction.
Median enrollment 161 across the 14 interventional studies, 350 across the 9 observational. Of the 12 that completed or were terminated, 3 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 23 have an industry lead sponsor. The 10 most frequent:
Medical University Innsbruck is the lead sponsor of 187 studies on the registry; 48 are open to participants now.
Medical University Innsbruck has 4 studies filed under ST Elevation Myocardial Infarction — fewer than ten, so there is no comparison to draw.
1 of the studies in ST Elevation Myocardial Infarction with a site in Austria that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07780552VASCage GmbHCHIP in Health and Disease | 2027-03 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in ST Elevation Myocardial Infarction with a site in Austria, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cardiovascular magnetic resonance imaging enables comprehensive assessment of cardiovascular function, morphology and pathology. The investigators aim to evaluate the nature and clinical significance of magnetic resonance imaging parameters in patients presenting with first acute ST-elevation myocardial infarction.
Patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention admitted to the coronary care unit of Innsbruck University Hospital for Internal Medicine III (Cardiology and Angiology).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Diagnostic Test: Cardiovascular Magnetic Resonance Imaging
Cardiovascular magnetic resonance imaging will be performed within the first week after ST-elevation myocardial infarction and in a defined subgroup 4 months, 12 months and 10 years thereafter.
Occurence of major adverse cardiovascular events
Time frame: 1 - 5 years
Infarct size assessment (% of left ventricular myocardial mass)
Time frame: baseline, 4 months and 12 months
Assessment of infarct transmurality grade (%) with late gadolinium enhancement imaging
Time frame: baseline, 4 months and 12 months
Occurence and area of microvascular obstruction
Time frame: baseline
Intramyocardial haemorrhage assessed by T2* imaging
Time frame: baseline, 4 months and 12 months
Tissue characterisation by T1, T2 and T2* Mapping
Time frame: baseline, 4 months and 12 months
Myocardial deformation by strain analysis
Time frame: baseline, 4 months and 12 months
Chamber volumes by cine imaging
Time frame: baseline, 4 months and 12 months
Cardiac function by cine imaging
Time frame: baseline, 4 months and 12 months
Stroke volumes by phase contrast imaging
Time frame: baseline, 4 months and 12 months
Aortic pulse wave velocity and distensibility by phase contrast imaging
Time frame: baseline, 4 months and 12 months
Aortic pulse wave distensibility by phase contrast imaging
Time frame: baseline, 4 months and 12 months
Quality of life and invalidity assessment (Global Physical Activity Questionnaire)
Time frame: 1 - 5 years
Biomarker release during the acute and subacute phase
biomarker concentrations of hemodynamic stress (n-terminal pro-B-type natriuretic peptide), neurohumoral markers (i.e. neprilysin ng/ml), inflammatory markers (i.e. procalcitonin µg/l) and markers of myocardial injury (i.e. high sensitivity cardiac troponin T ng/l)
Time frame: baseline, 4 months and 12 months
Parameters of cardiac function by transthoracic echocardiography
Time frame: baseline, 4 months and 12 months
Plaque volume by 3D ultrasound
Time frame: baseline, 12 months
Cardiac autonomic function
Deceleration capacity of heart rate
Time frame: baseline, 4 months and 12 months
Cardiac autonomic function
Heart rate variability
Time frame: baseline, 4 months and 12 months
Cardiac autonomic function
Periodic repolarization dynamics
Time frame: baseline, 4 months and 12 months
Cardiac autonomic function
Baroreflex sensitivity
Time frame: baseline, 4 months and 12 months
Cardiac autonomic function
Skin sympathetic nerve activity
Time frame: baseline, 4 months and 12 months
Started Jan 2011 (actual). Primary completion is estimated for Jun 2026, 185 months after the start.
Of 122 non-industry observational studies under ST Elevation Myocardial Infarction, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 107. This study's planned 185 months is above that.
Counting every sponsor, half of 143 studies reached it within 38 months; a quarter within 21 and three quarters within 73.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ST Elevation Myocardial Infarction →
Medical University Innsbruck →